Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2017
From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials WiselyDaphne Day, Arta M Monjazeb, Elad Sharon, et al.Translational Oncology|November 23, 2020
Enhanced toxicity with CDK 4/6 inhibitors and palliative radiotherapy: Non-consecutive case series and review of the literatureSteven David, Gwo Ho, Daphne Day, et al.Asia-Pacific Journal of Clinical Oncology|February 1, 2019
Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter studyFrancis J Ha, Lavinia Spain, Anthony Dowling, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 7, 2024
Improving communication skills in caregivers: an adaptation and pilot test of a brief training module for caregivers of people with cancer in AustraliaEva Y N Yuen, Joy Goldsmith, Carlene Wilson, et al.Asia-Pacific Journal of Clinical Oncology|January 19, 2022
COVID-19 vaccination rates, intent, and hesitancy in patients with solid organ and blood cancers: A multicenter studyMike Nguyen, Nathan Bain, Lisa Grech, et al.BJU International|July 25, 2015
Patterns of care for metastatic renal cell carcinoma in AustraliaDaphne Day, Yada Kanjanapan, Edmond Kwan, et al.Acta Haematologica|January 30, 2024
Attitudes towards COVID-19 Vaccination in Adults with Haematological MalignanciesRichard Blennerhassett, Nada Hamad, Lisa Grech, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2016
Conditional Survival of Patients With Metastatic Testicular Germ Cell Tumors Treated With First-Line Curative TherapyJenny J Ko, Brandon Bernard, Ben Tran, et al.British Journal of Cancer|April 15, 2025
First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumorsDaphne Day, Vinod Ganju, Ki Chung, et al.Immunotherapy|September 12, 2024
A phase 1 study of the CD40 agonist MEDI5083 in combination with durvalumab in patients with advanced solid tumorsBen Tran, Mark Voskoboynik, Johanna Bendell, et al.Pageof 4